AstraZeneca Annual Report and Financial Statements Form 20-F Information 2003 111 35 Called-up share capital of parent company Allotted, called-up Authorised and fully paid 2003 2003 2002 $m $m $m Ordinary Shares $0.25 each 423 423 429 Unissued Ordinary Shares $0.25 each 177 Redeemable Preference Shares 1 each 50,000 600 423 429 The Redeemable Preference Shares carry limited class voting rights and no dividend rights.
This class of shares is capable of redemption at par at the option of the Company on the giving of seven days written notice to the registered holder of the shares.
The movements in share capital during the year can be summarised as follows: No.
of shares million $m At beginning of year 1,719 429 Issues of shares 11 Re-purchase of shares 27 7 At 31 December 2003 1,693 423 Share buy-back During the year the Company purchased, and subsequently cancelled, 27,211,500 Ordinary Shares at an average price of 2535 pence per share for a consideration, including expenses, of $1,154m.
The excess of the consideration over the nominal value has been charged against the profit and loss account reserve.
Share schemes A total of 1,240,117 Ordinary Shares were issued during the year in respect of share schemes.
Details of movements in the number of Ordinary Shares under option are shown in Note 30: details of options granted to Directors are shown in the Directors Remuneration Report.
